Clinical Approach to Mood or Sleep Disturbance
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of perinatal mood and sleep disturbances
Perinatal mood and sleep disturbances represent one of the most common complications of pregnancy and the postpartum period, affecting approximately 15 to 20% of women. These conditions account for significant morbidity in obstetric practice, with postpartum depression alone affecting roughly 1 in 7 women. Sleep disturbances occur in up to 78% of pregnant women and persist in approximately 60% during the postpartum period. Despite their prevalence, up to 50% of cases remain undiagnosed, making systematic screening and recognition essential for optimal maternal and infant outcomes.
Definition
Perinatal mood disturbance encompasses a spectrum of affective disorders occurring during pregnancy or within the first year postpartum, ranging from transient “baby blues” to severe postpartum psychosis. Perinatal sleep disturbance refers to disruptions in sleep architecture, duration, or quality during pregnancy or the postpartum period that exceed normal physiological adaptations and cause functional impairment. These conditions frequently co-occur and share overlapping risk factors and pathophysiology.
Key Epidemiology
- Postpartum blues: 50 to 85% of women (transient, self-limiting)
- Postpartum depression: 10 to 20% of women
- Postpartum anxiety disorders: 10 to 15% of women
- Postpartum psychosis: 0.1 to 0.2% of women (1 to 2 per 1,000 deliveries)
- Antenatal depression: 10 to 15% of pregnant women
- Clinically significant sleep disturbance: 25 to 40% throughout perinatal period
Classification by Timing and Duration
| Category | Onset | Duration | Clinical Significance |
|---|---|---|---|
| Postpartum Blues | Days 2 to 5 postpartum | Less than 2 weeks (typically resolves by day 10 to 14) | Normal adaptation; no treatment required but monitor for progression |
| Acute Postpartum Depression | Within 4 weeks postpartum (DSM-5 specifier) | Greater than 2 weeks | Requires active intervention; high risk period for infant bonding disruption |
| Postpartum Depression (Clinical) | Within 12 months postpartum | Weeks to months if untreated | Most common; majority present 2 to 3 months postpartum |
| Antenatal Depression | During pregnancy | Variable; may persist postpartum | Strong predictor of postpartum depression; affects fetal development |
| Postpartum Psychosis | Usually within 48 hours to 2 weeks postpartum | Psychiatric emergency | Requires immediate hospitalization; risk of infanticide and suicide |
Classification by Predominant Symptom Pattern
Mood-Predominant Presentations
Depressive type: Persistent sadness, anhedonia, guilt, worthlessness, hopelessness, passive death wishes or suicidal ideation
Anxious type: Excessive worry, intrusive thoughts, panic symptoms, hypervigilance about infant, obsessive concerns about infant safety
Mixed anxious-depressive: Most common presentation; overlapping depressive and anxiety symptoms
Irritable/Angry type: Irritability, anger outbursts, resentment toward infant or partner; often underrecognized
Sleep-Predominant Presentations
Insomnia type: Difficulty initiating or maintaining sleep despite opportunity and infant sleeping; often anxiety-related
Hypersomnia type: Excessive daytime sleepiness, difficulty waking, prolonged sleep despite adequate opportunity
Fragmented sleep type: Normal for postpartum period but becomes pathological when causing significant functional impairment
Sleep-related anxiety: Fear of sleeping, hypervigilance about infant preventing sleep, checking behaviors
Classification by Severity
| Severity | Clinical Features | Functional Impact | Management Setting |
|---|---|---|---|
| Mild | Symptoms present but manageable; no psychotic features; no suicidal ideation | Minor interference with daily activities and infant care | Outpatient; psychotherapy first-line |
| Moderate | Significant symptom burden; possible passive death wishes; no active suicidal plan | Moderate interference with self-care, infant care, and relationships | Outpatient with close follow-up; pharmacotherapy often indicated |
| Severe | Severe symptoms; active suicidal ideation; possible psychotic features | Unable to function or care for infant safely | May require psychiatric admission; mother-baby unit if available |
| Psychotic | Delusions, hallucinations, disorganized behavior, command hallucinations | Psychiatric emergency; risk to self and infant | Immediate psychiatric hospitalization required |
Classification by Associated Features
| Pattern | Description | Clinical Implications |
|---|---|---|
| With anxious distress | Prominent anxiety, worry, restlessness, fear of losing control | May need anxiolytic adjunct; higher suicide risk |
| With obsessive features | Intrusive thoughts (often of harming infant), compulsive checking | Distinguish from psychosis; thoughts are ego-dystonic; responds to SSRI therapy |
| With prominent insomnia | Inability to sleep even when infant sleeps; early warning sign | Sleep restoration critical to recovery; may need targeted sleep intervention |
| With bonding difficulties | Emotional detachment from infant, lack of maternal feelings | Requires specific therapeutic focus on attachment; not volitional |
| With somatic symptoms | Fatigue, appetite changes, headaches, diffuse pain | Rule out medical causes; may be primary presentation |
Key Concept: The Perinatal Mood Spectrum
Perinatal mood disturbances exist on a spectrum from normal postpartum adjustment to psychiatric emergency. The “Big Four” conditions to distinguish are:
- Postpartum blues — transient, self-limiting, reassurance only
- Postpartum depression — most common, treatable, good prognosis with intervention
- Postpartum anxiety disorders — frequently comorbid with depression, often overlooked
- Postpartum psychosis — rare but life-threatening emergency requiring immediate hospitalization
Sleep disturbance is both a symptom of and risk factor for mood disorders — inability to sleep when the infant sleeps is a critical warning sign that should prompt immediate assessment.
Impact on Mother and Infant
Untreated perinatal mood and sleep disturbances have significant consequences:
- Maternal: Increased suicide risk (leading cause of maternal mortality in developed countries), substance use, relationship breakdown, chronic mental illness
- Infant: Impaired bonding and attachment, cognitive and emotional developmental delays, behavioral problems, increased risk of child abuse and neglect
- Family: Partner depression, relationship discord, sibling effects, economic burden
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of perinatal mood and sleep disturbances
The pathophysiology of perinatal mood and sleep disturbances is multifactorial, involving a complex interplay of hormonal fluctuations, neurobiological changes, sleep deprivation, and psychosocial stressors. The postpartum period represents a time of dramatic physiological change unparalleled in adult life, with estrogen and progesterone levels falling more than 100-fold within the first few days after delivery. Understanding these mechanisms helps clinicians appreciate why some women are particularly vulnerable and guides targeted therapeutic interventions.
Hormonal Fluctuations and Their Effects
| Hormone | Perinatal Change | Mechanism of Mood/Sleep Effect |
|---|---|---|
| Estrogen | Rises 100-fold during pregnancy; drops precipitously within 48 hours postpartum | Modulates serotonin, dopamine, and norepinephrine systems; rapid withdrawal triggers mood instability in susceptible women |
| Progesterone | High during pregnancy; falls rapidly postpartum | Acts on GABA-A receptors (anxiolytic and sedative); withdrawal causes anxiety, insomnia, and irritability |
| Allopregnanolone | Neuroactive progesterone metabolite; rises in pregnancy, falls postpartum | Potent positive modulator of GABA-A receptors; deficiency linked to postpartum depression (target of brexanolone) |
| Cortisol | Elevated in pregnancy; HPA axis dysregulation postpartum | Chronic elevation disrupts sleep architecture; HPA axis hyperactivity associated with depression |
| Thyroid hormones | Postpartum thyroiditis in 5 to 10% of women | Both hyper- and hypothyroidism cause mood symptoms; thyroiditis mimics depression |
| Oxytocin | Surges during labor, breastfeeding | Promotes bonding and anxiolysis; dysregulation may impair mother-infant attachment |
| Prolactin | Elevated with breastfeeding | Affects sleep architecture (increases slow-wave sleep); may contribute to fatigue |
Neurobiological Mechanisms
Monoamine Systems
Serotonin: Estrogen withdrawal reduces serotonin synthesis and receptor sensitivity; forms basis for SSRI efficacy
Dopamine: Reward pathway alterations may underlie anhedonia and reduced motivation
Norepinephrine: Dysregulation contributes to anxiety, hypervigilance, and sleep disruption
GABAergic System
GABA-A receptors: Key target of neuroactive steroids; withdrawal of progesterone metabolites reduces GABAergic tone
Clinical relevance: Explains why brexanolone (allopregnanolone analog) is effective in postpartum depression
Sleep connection: GABAergic deficiency promotes insomnia and anxiety
HPA Axis
Pregnancy: Placental CRH production creates relative HPA axis suppression
Postpartum: HPA axis “reawakening” with potential hyperactivity in vulnerable women
Result: Elevated cortisol, impaired stress response, sleep disruption
Sleep Physiology in the Perinatal Period
| Component | Normal Perinatal Changes | Pathological Changes |
|---|---|---|
| Sleep architecture | Reduced REM and slow-wave sleep in late pregnancy; fragmented sleep postpartum due to infant care | Further REM suppression; failure to return to consolidated sleep; persistent early morning awakening |
| Sleep duration | Average 6 to 7 hours (fragmented) in early postpartum | Less than 4 hours total; inability to sleep even when opportunity exists |
| Circadian rhythm | Disruption from irregular infant feeding schedule | Complete loss of circadian synchronization; may trigger bipolar episodes |
| Sleep latency | May increase slightly due to discomfort or anxiety | Prolonged (greater than 30 minutes); racing thoughts preventing sleep onset |
| Sleep-related breathing | Pregnancy: increased snoring, positional dyspnea; usually resolves postpartum | Undiagnosed obstructive sleep apnea contributing to fatigue and mood symptoms |
Critical Concept: The Bidirectional Sleep-Mood Relationship
Sleep disturbance and mood disorders have a bidirectional relationship in the perinatal period:
- Sleep deprivation → mood symptoms: Even in non-vulnerable women, severe sleep deprivation can trigger depressive and anxious symptoms
- Mood symptoms → sleep disturbance: Depression causes early morning awakening; anxiety causes sleep-onset insomnia and hypervigilance
- Critical warning sign: Inability to sleep when the infant sleeps suggests pathological process rather than normal postpartum adaptation
- Therapeutic implication: Protecting and restoring sleep is a primary treatment target
How Specific Conditions Develop
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Postpartum blues | Normal physiological response to acute hormone withdrawal; typically self-corrects as systems equilibrate | Reassurance, support, sleep protection; no pharmacotherapy needed |
| Postpartum depression | Vulnerability to hormone withdrawal combined with sleep deprivation, psychosocial stress, and possible prior sensitization of stress systems | SSRIs restore serotonergic function; brexanolone restores GABAergic tone; psychotherapy addresses cognitive patterns |
| Postpartum anxiety and obsessive-compulsive disorder | Hyperactivation of threat-detection systems; noradrenergic dysregulation; intrusive thoughts may relate to oxytocin system changes | SSRIs effective; benzodiazepines for acute symptoms; CBT for intrusive thoughts |
| Postpartum psychosis | Dramatic circadian disruption combined with hormone withdrawal in women with bipolar diathesis; immune/inflammatory factors may contribute | Mood stabilizers, antipsychotics essential; sleep restoration critical; high recurrence risk in future pregnancies |
| Postpartum insomnia disorder | Conditioned arousal around sleep; cognitive hyperarousal; loss of sleep drive from fragmentation; may persist after infant sleeps through | Cognitive behavioral therapy for insomnia (CBT-I) is first-line; sleep restriction, stimulus control |
Neurobiological Vulnerability Factors
Genetic and Biological
- Prior mood episodes: Prior depression increases risk 25 to 50%; prior postpartum depression increases risk to 50%
- Bipolar disorder: 25 to 50% risk of postpartum episode; highest risk for psychosis
- Family history: First-degree relative with postpartum depression increases risk 2 to 3 fold
- Hormonal sensitivity: History of PMDD or mood symptoms with hormonal contraceptives suggests vulnerability
- Thyroid antibodies: Positive antibodies increase postpartum thyroiditis and depression risk
Psychosocial and Environmental
- Sleep deprivation: Both a trigger and consequence; critical modifiable factor
- Social support: Isolation strongly predicts depression
- Partner relationship: Conflict is significant risk factor
- Life stressors: Financial stress, housing insecurity, recent losses
- Birth experience: Traumatic birth, emergency cesarean, NICU admission
- Breastfeeding difficulties: Both a stressor and may affect hormonal milieu
Emerging Concepts: Inflammation and Immune Factors
Neuroimmune Mechanisms
Emerging research suggests that immune dysregulation plays a role in perinatal mood disorders:
- Pregnancy: Represents a state of immune tolerance; shift toward anti-inflammatory T-helper 2 response
- Postpartum: Rapid immune rebound may trigger inflammatory cascade in vulnerable women
- Inflammatory markers: Elevated C-reactive protein and interleukin-6 associated with postpartum depression
- Sleep connection: Sleep deprivation itself is pro-inflammatory, potentially creating a vicious cycle
- Therapeutic implications: May explain efficacy of anti-inflammatory adjuncts; omega-3 fatty acids under investigation
Often Overlooked Mechanism
The role of allopregnanolone deficiency: Allopregnanolone is a progesterone metabolite that acts as a potent positive allosteric modulator of GABA-A receptors. During pregnancy, allopregnanolone levels rise dramatically (up to 10-fold), then fall precipitously after delivery. In susceptible women, GABA-A receptors fail to adapt to this withdrawal, resulting in reduced GABAergic inhibition and subsequent anxiety, insomnia, and depression. This mechanism is the basis for brexanolone (IV allopregnanolone), the first FDA-approved treatment specifically for postpartum depression, demonstrating rapid efficacy within 48 hours.
Integrated Pathophysiology Model
Hormonal Withdrawal
Estrogen and progesterone crash
Allopregnanolone deficiency
Thyroid fluctuations
HPA axis reactivation
Neurobiological Changes
Serotonin system downregulation
GABAergic tone reduction
Circadian disruption
Inflammatory activation
Sleep Disruption
Fragmentation from infant care
Loss of slow-wave sleep
Circadian misalignment
Conditioned insomnia
Psychosocial Stressors
Role transition
Social isolation
Relationship stress
Economic pressures
3. History Taking
A comprehensive approach to eliciting the perinatal mood and sleep disturbance history
Red Flags — Require Urgent Evaluation
- Suicidal ideation or intent — Immediate psychiatric evaluation; suicide is leading cause of maternal mortality
- Thoughts of harming the infant — Distinguish intrusive ego-dystonic thoughts (common in anxiety) from psychotic command hallucinations (emergency)
- Psychotic symptoms — Delusions, hallucinations, disorganized speech or behavior; postpartum psychosis is psychiatric emergency
- Inability to sleep despite exhaustion — Key warning sign for impending psychosis or severe depression
- Inability to care for self or infant — Not eating, not attending to infant’s basic needs
- Rapid mood cycling — Elation alternating with depression suggests bipolar disorder
- Bizarre beliefs about infant — Infant is evil, possessed, or not theirs; may indicate psychosis
- Complete emotional detachment — No emotional response to infant; may indicate severe depression or dissociation
Mandatory Safety Screening Questions
Ask every patient directly and privately:
- “Have you had thoughts of hurting yourself or not wanting to be alive?”
- “Have you had any scary or unwanted thoughts about your baby?”
- “Do you feel safe at home? Is anyone hurting you or threatening you?”
- “Are you able to sleep when the baby sleeps, or is something preventing you from sleeping?”
Important: Normalize the conversation — “I ask all new mothers these questions because these feelings are common and treatable.”
Systematic History: The “DREAMS” Approach
Use the mnemonic “DREAMS” to ensure comprehensive history taking for perinatal mood and sleep disturbances:
- D — Duration and Depression screening: When did symptoms start? Use validated screening tools (Edinburgh Postnatal Depression Scale, Patient Health Questionnaire-9). How long have you been feeling this way?
- R — Rest and sleep patterns: Can you sleep when the baby sleeps? How many hours total? What prevents you from sleeping? Do you feel rested?
- E — Emotions and experiences: What emotions are you experiencing? Sadness, anxiety, irritability, numbness? Any frightening or intrusive thoughts? How do you feel about your baby?
- A — Anxiety and appetite: Excessive worry? Panic attacks? Obsessive thoughts or checking behaviors? Appetite changes? Weight changes?
- M — Medical and psychiatric history: Prior depression, anxiety, or bipolar disorder? Family psychiatric history? Thyroid problems? Current medications?
- S — Support and stressors: Who is helping you? Partner involvement? Relationship quality? Financial stressors? Birth experience? Breastfeeding challenges?
Validated Screening Tools
| Tool | What It Screens For | Scoring | Clinical Use |
|---|---|---|---|
| Edinburgh Postnatal Depression Scale (EPDS) | Perinatal depression and anxiety | 10 items; score 10 or above suggests depression; question 10 screens for self-harm | Gold standard for perinatal screening; validated in pregnancy and postpartum |
| Patient Health Questionnaire-9 (PHQ-9) | Major depressive disorder | 9 items; 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20+ severe | Widely used; tracks severity over time; item 9 screens for suicidality |
| Generalized Anxiety Disorder-7 (GAD-7) | Anxiety symptoms | 7 items; 5-9 mild, 10-14 moderate, 15+ severe anxiety | Useful for anxiety-predominant presentations |
| Pittsburgh Sleep Quality Index (PSQI) | Sleep quality over past month | Score greater than 5 indicates poor sleep quality | Helpful for quantifying sleep disturbance beyond normal postpartum changes |
| Insomnia Severity Index (ISI) | Insomnia severity | 7 items; 8-14 subthreshold, 15-21 moderate, 22+ severe insomnia | Quick assessment of insomnia independent of infant-related wakings |
Targeted Questions by Suspected Condition
| Suspected Condition | Key Features | Ask This Question |
|---|---|---|
| Postpartum blues | Onset days 2-5, tearfulness, mood lability, resolves by 2 weeks | “Did your symptoms start in the first week and have they been getting better over the past few days?” |
| Postpartum depression | Persistent low mood, anhedonia, guilt, sleep and appetite changes | “Do you still enjoy things you used to enjoy? Do you feel like a good mother, or do you feel like you’re failing?” |
| Postpartum anxiety | Excessive worry, physical tension, catastrophic thinking | “Do you find yourself worrying excessively about the baby’s health or safety? Do you have trouble relaxing or feel on edge?” |
| Postpartum obsessive-compulsive disorder | Intrusive thoughts (often of harming baby), compulsive checking | “Do you have unwanted, scary thoughts that pop into your head that you can’t control? Do you find yourself checking on the baby constantly?” |
| Postpartum post-traumatic stress disorder | Traumatic birth, flashbacks, avoidance, hyperarousal | “Did anything frightening happen during your labor or delivery? Do you have nightmares or flashbacks about the birth?” |
| Postpartum psychosis | Rapid onset, confusion, delusions, hallucinations, disorganized behavior | “Have you seen or heard things others don’t? Do you have any special beliefs about yourself or your baby that others don’t understand?” |
| Bipolar disorder with postpartum onset | Decreased need for sleep (energized), grandiosity, racing thoughts, impulsivity | “Have you felt unusually energetic, like you don’t need sleep? Have you had racing thoughts or started any new projects?” |
| Primary insomnia disorder | Cannot sleep even when infant sleeps, hyperarousal, conditioned sleeplessness | “When the baby sleeps, are you able to sleep, or do you lie awake even though you’re exhausted?” |
| Postpartum thyroiditis | Fatigue, mood changes, weight changes, palpitations | “Have you noticed palpitations, tremors, or feeling unusually hot or cold? Any significant weight changes?” |
Critical Distinction: Intrusive Thoughts vs. Psychotic Thoughts
Intrusive Thoughts (Anxiety/OCD)
- Ego-dystonic (distressing, unwanted)
- Patient recognizes thoughts as irrational
- Associated with avoidance behaviors
- Patient fears acting on thoughts
- Protective behaviors (checking, avoiding)
- Not dangerous; responds to SSRI therapy
Psychotic Thoughts
- Ego-syntonic (feels true to patient)
- Patient believes thoughts are real
- May have command hallucinations
- Disorganized thinking or behavior
- May act on delusional beliefs
- Psychiatric emergency; requires hospitalization
Psychiatric and Medical History
Key Psychiatric History Elements
- Prior perinatal episodes: Previous postpartum depression increases risk to 50%
- Prior depression or anxiety: Strongest predictor of perinatal mood disorder
- Bipolar disorder: Critical to identify; 25-50% risk of postpartum episode; antidepressant monotherapy contraindicated
- Family psychiatric history: First-degree relative with postpartum depression or bipolar disorder
- Prior trauma: Childhood abuse, sexual trauma, intimate partner violence
- Premenstrual dysphoric disorder: Suggests sensitivity to hormonal fluctuations
- Previous treatment response: What medications or therapies helped before?
Medical History Considerations
- Thyroid disease: History of thyroid problems or thyroid antibodies
- Anemia: Can cause fatigue, cognitive symptoms
- Diabetes: Association with perinatal depression
- Autoimmune disorders: Increased mood disorder risk
- Sleep disorders: Prior insomnia, sleep apnea (pregnancy may unmask)
- Chronic pain: Bidirectional relationship with depression
- Substance use history: Current or prior alcohol, cannabis, opioid, or other substance use
Medication and Substance History
Medications That Affect Mood or Sleep
- Beta-blockers: Can cause depression, fatigue, sleep disturbance
- Corticosteroids: Mood lability, insomnia, psychosis at high doses
- Opioids: Mood effects, sleep disruption, dependence
- Benzodiazepines: Withdrawal can cause anxiety, insomnia
- Antihistamines: Sedation, next-day fatigue
- Hormonal contraceptives: Some women sensitive to progestins
- Recent discontinuation of antidepressants: May have stopped in pregnancy
Substance Use Screening
- Alcohol: Screen with validated tool; often underreported postpartum
- Cannabis: Increasingly common; may worsen anxiety, affect breastfeeding
- Caffeine: Excessive use to combat fatigue; worsens sleep and anxiety
- Nicotine: Stimulant effects; sleep disruption
- Prescription misuse: Opioids from delivery, benzodiazepines
- Over-the-counter sleep aids: May mask underlying disorder
Psychosocial Assessment
| Domain | Key Questions | Clinical Significance |
|---|---|---|
| Partner and relationship | “How is your relationship with your partner? Are they supportive? Any conflict?” | Partner conflict is major risk factor; partner depression common |
| Social support | “Who can you call if you need help with the baby? Do you have family or friends nearby?” | Isolation strongly predicts depression; practical support is protective |
| Intimate partner violence | “Do you feel safe at home? Has anyone hurt you or threatened you?” | Risk increases in pregnancy and postpartum; screen privately |
| Financial stressors | “Are you worried about money, housing, or being able to afford what your baby needs?” | Economic stress is modifiable risk factor; connect to resources |
| Birth experience | “How was your birth experience? Was there anything frightening or unexpected?” | Traumatic birth predicts PTSD; cesarean, NICU admission are risk factors |
| Breastfeeding | “How is breastfeeding going? Is it causing you stress?” | Breastfeeding difficulties are stressor; success can be protective |
| Infant factors | “How is the baby’s temperament? Does the baby have any health concerns?” | Colicky infant, infant illness, or NICU stay increase maternal stress |
| Return to work | “Are you planning to return to work? Do you have concerns about childcare?” | Transition stress; inadequate maternity leave is risk factor |
Detailed Sleep History
Key Sleep Questions to Ask:
- Opportunity: “When the baby sleeps, do you have the opportunity to sleep?”
- Ability: “When you have the opportunity to sleep, are you able to fall asleep? Stay asleep?”
- Duration: “In a 24-hour period, how many total hours of sleep do you get?”
- Quality: “Do you feel rested when you wake up, or do you still feel exhausted?”
- Onset: “How long does it take you to fall asleep? What keeps you awake?”
- Maintenance: “Do you wake up in the night apart from when the baby wakes? Can you fall back asleep?”
- Early awakening: “Do you wake up very early in the morning and can’t get back to sleep?”
- Hypervigilance: “Do you lie awake listening for the baby? Do you check on the baby frequently?”
- Nightmares: “Do you have bad dreams or nightmares? About what?”
- Bed partner observation: “Has your partner noticed snoring, gasping, or unusual movements?”
4. Physical Examination
A systematic approach for evaluating patients with perinatal mood and sleep disturbances
Systematic Framework: The physical examination in perinatal mood and sleep disturbance serves two purposes: (1) identifying medical conditions that may cause or contribute to symptoms, and (2) assessing severity through observable signs. Use a “General to Focused” approach, paying particular attention to thyroid, neurological, and mental status examination.
General Inspection
- Appearance: Grooming, hygiene, dress — neglect may indicate severity; disheveled appearance concerning
- Psychomotor activity: Psychomotor retardation (slowed movements, speech) or agitation (restlessness, hand-wringing)
- Affect: Flat, blunted, tearful, anxious, irritable, inappropriate, or labile
- Eye contact: Poor eye contact may indicate depression; hypervigilance may indicate anxiety
- Interaction with infant: If infant present, observe bonding, responsiveness, handling of infant
- Signs of fatigue: Dark circles, yawning, difficulty staying awake during examination
- Weight and nutritional status: Visible weight loss or gain since pregnancy
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Heart Rate | Tachycardia (greater than 100 bpm) or bradycardia | Tachycardia: anxiety, hyperthyroidism, anemia, dehydration. Bradycardia: hypothyroidism, medication effect |
| Blood Pressure | Hypertension or hypotension | Persistent postpartum hypertension may cause headache, anxiety; hypotension with dehydration or adrenal insufficiency |
| Temperature | Fever or hypothermia | Fever: postpartum infection (endometritis, mastitis, wound infection); hypothermia: severe hypothyroidism |
| Respiratory Rate | Tachypnea at rest | May indicate anxiety, panic, or underlying cardiopulmonary pathology |
| Weight | Compare to pre-pregnancy and immediate postpartum weight | Significant loss: depression with anorexia, hyperthyroidism. Failure to lose: hypothyroidism, binge eating |
| Oxygen Saturation | Hypoxia (less than 95%) | May indicate sleep apnea with daytime hypoxemia; pulmonary embolism (rare but serious postpartum) |
Mental Status Examination
Structured Mental Status Examination
Document each component systematically:
| Component | What to Assess | Abnormal Findings and Significance |
|---|---|---|
| Appearance | Grooming, hygiene, dress, posture | Poor hygiene, inappropriate dress, slumped posture suggest severe depression |
| Behavior | Psychomotor activity, eye contact, cooperation | Retardation suggests depression; agitation suggests anxiety, mania, or psychosis |
| Speech | Rate, volume, tone, spontaneity | Slow, soft, monotone = depression. Rapid, pressured = mania. Disorganized = psychosis |
| Mood | Patient’s subjective report of emotional state | “Sad,” “numb,” “anxious,” “irritable,” or “fine” (may be incongruent with affect) |
| Affect | Observed emotional expression: range, intensity, congruence | Flat = severe depression. Labile = mood instability. Inappropriate = psychosis |
| Thought Process | Organization, coherence, goal-directedness | Tangential, circumstantial, or disorganized thinking concerning for psychosis |
| Thought Content | Suicidal/homicidal ideation, delusions, obsessions | Document presence and nature of any concerning thoughts; distinguish intrusive vs. psychotic |
| Perceptions | Hallucinations (auditory, visual, tactile) | Any hallucinations in postpartum period require urgent psychiatric evaluation |
| Cognition | Orientation, attention, concentration, memory | Confusion or disorientation suggests psychosis, delirium, or medical cause |
| Insight | Recognition that symptoms represent illness | Poor insight concerning; often impaired in psychosis and mania |
| Judgment | Decision-making capacity, safety awareness | Impaired judgment regarding infant care is particularly concerning |
Thyroid Examination
Inspection and Palpation
- Size: Diffuse enlargement suggests postpartum thyroiditis
- Nodules: Palpable nodules warrant further evaluation
- Tenderness: Pain suggests subacute thyroiditis (rare)
- Movement with swallowing: Normal thyroid moves with swallowing
Signs of Thyroid Dysfunction
- Hyperthyroidism: Tremor, warm moist skin, tachycardia, lid lag, brisk reflexes, weight loss
- Hypothyroidism: Dry skin, bradycardia, delayed reflexes, constipation, weight gain, cold intolerance
- Clinical tip: Postpartum thyroiditis often presents with hyperthyroid phase first, then hypothyroid
Neurological Examination
| Component | What to Assess | Significance |
|---|---|---|
| Cranial nerves | Gross assessment of CN II-XII | Focal deficits suggest structural lesion; rare but must exclude |
| Motor examination | Strength, tone, involuntary movements | Weakness: postpartum stroke, myasthenia. Tremor: anxiety, hyperthyroidism |
| Deep tendon reflexes | Compare bilateral, note briskness or delay | Hyperreflexia: hyperthyroidism, preeclampsia (if hypertensive). Hyporeflexia: hypothyroidism |
| Cerebellar function | Coordination, gait if concerned | Ataxia concerning for posterior circulation stroke, medication toxicity |
| Signs of raised intracranial pressure | Papilledema (fundoscopy if headache or visual changes) | Postpartum cerebral venous thrombosis can present with headache and mood changes |
Breast Examination (if breastfeeding)
- Inspection: Erythema, swelling, skin changes
- Palpation: Tenderness, masses, engorgement
- Mastitis signs: Localized erythema, warmth, tenderness, fever — can contribute to mood symptoms
- Nipple examination: Cracking, bleeding, signs of infection — breastfeeding pain is significant stressor
Postpartum-Specific Examination
Abdominal Examination
- Uterine involution: Tender, boggy uterus may indicate endometritis
- Cesarean incision: Signs of infection (erythema, discharge, dehiscence)
- Diastasis recti: May contribute to body image concerns
Perineal Examination (if indicated)
- Healing: Episiotomy or laceration healing
- Hematoma: Pain out of proportion, swelling
- Infection: Erythema, purulent discharge
- Pain: Persistent perineal pain is significant stressor
Expected Physical Findings by Condition
| Condition | General/Mental Status | Specific Physical Findings | Other Clues |
|---|---|---|---|
| Postpartum depression | Depressed affect, psychomotor slowing, poor grooming, tearfulness | Usually normal physical examination | Weight change, signs of sleep deprivation |
| Postpartum anxiety | Anxious affect, hypervigilant, restless | Tachycardia, tremor, sweating | Hyperventilation, muscle tension |
| Postpartum psychosis | Disorganized, confused, inappropriate affect, impaired insight | May appear normal or have signs of dehydration/self-neglect | Rapid fluctuation in mental status is characteristic |
| Postpartum thyroiditis (hyperthyroid phase) | Anxiety, irritability, agitation | Tachycardia, tremor, warm skin, hyperreflexia, possible goiter | Weight loss despite good appetite; 2-6 months postpartum typical |
| Postpartum thyroiditis (hypothyroid phase) | Fatigue, cognitive slowing, depressed mood | Bradycardia, dry skin, delayed reflexes, possible goiter | Constipation, cold intolerance; 4-8 months postpartum typical |
| Anemia | Fatigue, difficulty concentrating | Pallor (conjunctivae, palms, nail beds), tachycardia | History of postpartum hemorrhage; often overlooked |
| Sheehan syndrome (rare) | Fatigue, depression, cognitive changes | Hypotension, failure to lactate, loss of axillary/pubic hair | History of postpartum hemorrhage with hypotension |
| Sleep apnea | Excessive daytime sleepiness, cognitive impairment, irritability | Obesity (BMI greater than 30), large neck circumference, crowded oropharynx | Partner reports snoring, witnessed apneas |
Observation of Mother-Infant Interaction
If Infant is Present During Examination
Observe the following (note: many mothers with depression still provide adequate care):
- Physical handling: Holds infant close vs. at distance; supports head appropriately
- Eye contact with infant: Gazes at infant vs. avoids looking at infant
- Vocalization: Talks to infant, coos, uses “motherese” vs. silent or flat
- Response to infant cues: Notices and responds to infant’s signals vs. ignores or delayed response
- Emotional tone: Warm, affectionate vs. detached, hostile, or anxious
- Infant’s presentation: Well-nourished, clean, appropriately dressed, healthy-appearing
Document observations objectively. Bonding difficulties do not equate to intentional neglect — they are symptoms requiring treatment, not judgment.
Important Teaching Point
Normal physical examination is common! The majority of patients with postpartum depression, anxiety, and primary insomnia will have entirely normal physical examination findings. The examination’s primary purpose is to:
- Rule out medical conditions (thyroid disease, anemia, infection)
- Assess severity through mental status examination
- Identify safety concerns
- Observe mother-infant interaction if possible
A normal physical examination does not exclude significant perinatal mood disorder. Diagnosis rests primarily on history and validated screening tools.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The differential diagnosis of perinatal mood and sleep disturbance encompasses primary psychiatric disorders, medical conditions that mimic or cause psychiatric symptoms, and normal postpartum adjustment. A systematic approach prioritizes common conditions while maintaining vigilance for serious but treatable causes. The key clinical task is distinguishing normal postpartum adaptation from pathological states requiring intervention.
Primary Perinatal Mood Disorders
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| VERY COMMON (50-85%) | Postpartum blues | Onset days 2-5; tearfulness, mood lability, anxiety; self-limiting by day 10-14 | Symptoms persisting beyond 2 weeks; inability to care for infant; suicidal thoughts |
| COMMON (10-20%) | Postpartum depression | Persistent sadness, anhedonia, guilt, sleep/appetite changes, fatigue; onset typically 2-3 months postpartum | Suicidal ideation; thoughts of harming infant; inability to function; psychotic features |
| COMMON (10-15%) | Postpartum anxiety disorders | Excessive worry, panic attacks, physical symptoms of anxiety; often comorbid with depression | Severe avoidance behaviors; inability to care for infant due to anxiety |
| LESS COMMON (3-5%) | Postpartum obsessive-compulsive disorder | Intrusive thoughts (often about harming infant), compulsive checking; thoughts are ego-dystonic and distressing | Distinguish from psychosis: patient recognizes thoughts as irrational and fears acting on them |
| LESS COMMON (3-6%) | Postpartum post-traumatic stress disorder | Following traumatic birth; flashbacks, nightmares, avoidance of reminders, hyperarousal | Severe dissociation; avoidance of infant; suicidal ideation |
| UNCOMMON BUT SERIOUS (0.1-0.2%) | Postpartum psychosis | Rapid onset (usually within 2 weeks); confusion, delusions, hallucinations, disorganized behavior; often associated with bipolar disorder | PSYCHIATRIC EMERGENCY: Risk of suicide and infanticide; requires immediate hospitalization |
| UNCOMMON (1-2% postpartum onset) | Bipolar disorder | May present as depression, mania, or mixed episode; decreased need for sleep with energy is key feature of mania | Antidepressant monotherapy contraindicated; high risk of psychosis; family history important |
Step-by-Step Approach to Perinatal Mood Disturbance:
- Step 1: Exclude emergencies — Is there suicidal ideation? Psychotic symptoms? Risk to infant? If yes, urgent psychiatric evaluation
- Step 2: Determine timing — Onset within first 2 weeks and resolving? Likely postpartum blues. Persistent or worsening? Consider pathological cause
- Step 3: Screen for bipolar — Any history of mania, hypomania, or psychosis? Family history of bipolar? This changes management significantly
- Step 4: Rule out medical causes — Check thyroid function, complete blood count, basic metabolic panel in all patients
- Step 5: Characterize the presentation — Depression-predominant? Anxiety-predominant? Mixed? This guides treatment selection
Differential Diagnosis of Perinatal Sleep Disturbance
| Probability | Condition | Key Features | Distinguishing Clues |
|---|---|---|---|
| VERY COMMON (60-80%) | Normal postpartum sleep disruption | Fragmented sleep due to infant feeding; able to sleep when opportunity exists; improves as infant sleeps longer | Can fall asleep when infant sleeps; no mood symptoms beyond normal fatigue |
| COMMON (25-40%) | Sleep disturbance secondary to mood disorder | Insomnia or hypersomnia associated with depression or anxiety; cannot sleep even when infant sleeps | Accompanied by mood symptoms; early morning awakening (depression) or sleep-onset insomnia (anxiety) |
| LESS COMMON (5-10%) | Primary insomnia disorder (conditioned) | Developed conditioned arousal around sleep; hyperarousal at bedtime; persists even after infant sleeps through | Racing thoughts at bedtime; anxiety about sleep itself; responds to cognitive behavioral therapy for insomnia |
| LESS COMMON (5-10%) | Obstructive sleep apnea | Snoring, witnessed apneas, excessive daytime sleepiness, morning headaches; may worsen or emerge in pregnancy | Obesity, large neck, crowded airway; non-restorative sleep despite adequate duration |
| LESS COMMON | Restless legs syndrome | Uncomfortable urge to move legs, worse at rest and evening; common in pregnancy, may persist postpartum | Symptoms worse at night; iron deficiency exacerbates; relieved by movement |
| UNCOMMON | Circadian rhythm disorder | Complete loss of circadian synchronization from irregular infant schedule | Sleep timing shifted rather than total sleep reduced; may trigger bipolar episodes |
Medical Conditions Mimicking Perinatal Mood or Sleep Disturbance
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Postpartum thyroiditis | 5-10% of postpartum women | Biphasic: hyperthyroid (2-6 months) then hypothyroid (4-8 months); palpitations, weight changes, heat/cold intolerance |
| COMMON | Iron deficiency anemia | 10-30% postpartum | Fatigue, cognitive difficulties, palpitations; history of postpartum hemorrhage; check ferritin even if hemoglobin normal |
| LESS COMMON | Vitamin D deficiency | Variable by population | Fatigue, mood changes, muscle weakness; common in northern latitudes, dark skin, limited sun exposure |
| LESS COMMON | Vitamin B12 deficiency | Variable; higher in vegetarians | Fatigue, cognitive changes, paresthesias; consider in vegetarians, those with malabsorption |
| LESS COMMON | Postpartum infections | 1-3% | Endometritis, mastitis, wound infection; fever, localizing symptoms; infection can precipitate mood symptoms |
| UNCOMMON | Postpartum cardiomyopathy | 1 in 1,000-4,000 | Fatigue, dyspnea, edema; can be misattributed to normal postpartum changes; check BNP, echocardiogram if suspected |
| RARE | Sheehan syndrome | Rare in developed countries | Panhypopituitarism from postpartum hemorrhage; failure to lactate, fatigue, hypotension, hypothyroidism |
| RARE | Cerebral venous thrombosis | 1 in 10,000 pregnancies | Severe headache, seizures, focal deficits, altered mental status; prothrombotic state of pregnancy |
| RARE | Autoimmune encephalitis | Very rare | Psychiatric symptoms, seizures, movement disorders; consider in atypical psychosis unresponsive to treatment |
Categorical Approach to Differential Diagnosis
Primary Psychiatric
Postpartum depression
Postpartum anxiety disorders
Postpartum OCD
Postpartum PTSD
Postpartum psychosis
Bipolar disorder
Endocrine Causes
Postpartum thyroiditis
Hypothyroidism
Hyperthyroidism
Sheehan syndrome
Adrenal insufficiency
Diabetes (poorly controlled)
Hematologic and Nutritional
Iron deficiency anemia
Vitamin B12 deficiency
Folate deficiency
Vitamin D deficiency
Postpartum hemorrhage sequelae
Other Medical Causes
Postpartum infections
Sleep apnea
Postpartum cardiomyopathy
Cerebral venous thrombosis
Autoimmune conditions
Substance use disorders
Drug-Induced Mood and Sleep Disturbance
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Beta-blockers (e.g., labetalol) | CNS depression, sleep architecture disruption | Fatigue, depression, vivid dreams, sleep disturbance | Consider alternative antihypertensive if persistent postpartum hypertension |
| Opioids (postoperative) | CNS depression, sleep disruption, dependence | Sedation, cognitive dulling, constipation; withdrawal causes anxiety, insomnia | Taper as soon as appropriate; transition to non-opioid analgesia |
| Corticosteroids (if used) | HPA axis effects, direct CNS effects | Mood lability, insomnia, anxiety, psychosis at high doses | Taper if possible; psychiatric symptoms usually resolve with discontinuation |
| Antihistamines (for sleep or allergies) | Anticholinergic effects, next-day sedation | Drowsiness, cognitive impairment, paradoxical agitation | Avoid diphenhydramine for sleep; non-sedating antihistamines for allergies |
| Progestins (hormonal contraception) | Neuroactive steroid effects | Mood changes, depression in susceptible women | Consider non-hormonal or estrogen-containing options if mood effects |
| Antidepressant discontinuation | Serotonin withdrawal, recurrence of underlying disorder | Anxiety, irritability, insomnia, flu-like symptoms, mood deterioration | Many women stop antidepressants in pregnancy; consider restarting if symptomatic |
| Benzodiazepine discontinuation | GABA withdrawal | Severe anxiety, insomnia, tremor, rarely seizures | Gradual taper; avoid abrupt discontinuation |
| Excessive caffeine | Adenosine receptor blockade, sympathetic activation | Anxiety, insomnia, palpitations; often increased postpartum to combat fatigue | Counsel on moderate intake; avoid after early afternoon |
| Cannabis | Complex CNS effects | May worsen anxiety; cognitive effects; affects breastfeeding | Counsel on avoidance during breastfeeding; screen and treat |
| Alcohol | CNS depressant, sleep architecture disruption | May use to cope with mood symptoms; worsens depression, disrupts sleep | Screen with validated tool; brief intervention or referral as indicated |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Onset days 2-5, resolving by 2 weeks | Postpartum blues | Reassurance; schedule follow-up to confirm resolution |
| Cannot sleep even when infant sleeps | Depression, anxiety, or impending psychosis | Urgent evaluation; this is a key red flag |
| Intrusive thoughts of harming infant, patient horrified by thoughts | Postpartum OCD (anxiety-related) | Reassure these are common; SSRI therapy; NOT psychosis |
| Believes infant is evil or not hers, may act on beliefs | Postpartum psychosis | EMERGENCY: Immediate psychiatric evaluation and hospitalization |
| Decreased need for sleep WITH increased energy | Mania or hypomania (bipolar disorder) | Do NOT start antidepressant monotherapy; mood stabilizer needed |
| Traumatic birth, flashbacks, avoidance | Postpartum PTSD | Trauma-focused therapy; screen for comorbid depression |
| Palpitations, tremor, weight loss, anxiety | Hyperthyroidism (postpartum thyroiditis) | Check TSH, free T4; may be transient |
| Fatigue, cold intolerance, weight gain, constipation | Hypothyroidism | Check TSH, free T4; treat if confirmed |
| History of postpartum hemorrhage, fatigue, failure to lactate | Sheehan syndrome or severe anemia | Check hemoglobin, pituitary function tests |
| Snoring, witnessed apneas, unrefreshing sleep, daytime sleepiness | Obstructive sleep apnea | Sleep study; may need CPAP |
| Rapid onset, confusion, fluctuating mental status within 2 weeks of delivery | Postpartum psychosis | EMERGENCY: Rule out organic causes; psychiatric hospitalization |
| Severe headache, seizures, focal neurological signs | Cerebral venous thrombosis | Urgent neuroimaging (MR venography) |
Postpartum Blues vs. Postpartum Depression
Postpartum Blues
- Onset: Days 2-5 postpartum
- Duration: Resolves by day 10-14
- Severity: Mild, does not impair function
- Symptoms: Tearfulness, mood lability, anxiety
- Sleep: Can sleep when able
- Trajectory: Improving
- Treatment: Reassurance, support
Postpartum Depression
- Onset: Usually 2-3 months (but can be earlier)
- Duration: Persists beyond 2 weeks
- Severity: Moderate to severe; impairs function
- Symptoms: Persistent sadness, anhedonia, guilt, hopelessness
- Sleep: Cannot sleep even when infant sleeps
- Trajectory: Stable or worsening
- Treatment: Therapy, medication, support
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Laboratory and other investigations in perinatal mood and sleep disturbance serve to exclude medical conditions that mimic or contribute to psychiatric symptoms. The diagnosis of primary perinatal mood disorders remains clinical, based on history, validated screening tools, and mental status examination. Investigations should be guided by clinical suspicion while ensuring that common treatable conditions (particularly thyroid dysfunction and anemia) are not missed.
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Thyroid-stimulating hormone (TSH) | Screen for thyroid dysfunction | Low TSH (hyperthyroid phase) or high TSH (hypothyroid phase); postpartum thyroiditis affects 5-10% | Essential in ALL patients with perinatal mood symptoms; repeat in 6-8 weeks if initially abnormal |
| Free thyroxine (free T4) | Confirm thyroid dysfunction if TSH abnormal | High in hyperthyroidism; low in hypothyroidism | Order reflexively if TSH abnormal; helps distinguish severity |
| Complete blood count (CBC) | Screen for anemia | Low hemoglobin, low MCV (iron deficiency), high MCV (B12/folate deficiency) | Anemia common postpartum, especially after hemorrhage; contributes to fatigue and mood symptoms |
| Ferritin | Assess iron stores | Low ferritin (less than 30 ng/mL) indicates iron deficiency even with normal hemoglobin | Iron deficiency without anemia causes fatigue, cognitive symptoms; very common postpartum |
| Basic metabolic panel | Screen for electrolyte abnormalities, renal function | Hyponatremia, hypercalcemia, uremia can affect mood and cognition | Also assesses hydration status; dehydration common with breastfeeding |
| Validated screening tool (EPDS or PHQ-9) | Quantify symptom severity; screen systematically | EPDS ≥10 or PHQ-9 ≥10 suggests depression; always review item about self-harm | Universal screening recommended; can track response to treatment |
Minimum Investigation Panel
For every patient presenting with perinatal mood or sleep disturbance, order at minimum:
- TSH (and free T4 if abnormal)
- CBC
- Ferritin
- Validated screening tool (EPDS or PHQ-9)
These tests are low-cost, low-risk, and identify common treatable conditions.
Targeted Investigations by Suspected Etiology
If Suspecting Thyroid Dysfunction
First-Line Tests
- TSH: Sensitive screening test; low in hyperthyroidism, high in hypothyroidism
- Free T4: Confirms functional thyroid status
Second-Line Tests
- Free T3: If hyperthyroid symptoms with normal T4 (T3 toxicosis)
- Thyroid peroxidase (TPO) antibodies: Positive in autoimmune thyroiditis; predicts risk of progression to permanent hypothyroidism
- TSH receptor antibodies: If Graves’ disease suspected (rare postpartum)
If Suspecting Anemia or Nutritional Deficiency
First-Line Tests
- CBC with indices: Hemoglobin, MCV, MCH for anemia characterization
- Ferritin: Most sensitive marker of iron deficiency; less than 30 ng/mL is deficient
- Vitamin D (25-hydroxyvitamin D): Deficiency common; less than 20 ng/mL is deficient, less than 30 ng/mL is insufficient
Second-Line Tests
- Vitamin B12: If macrocytic anemia, vegetarian diet, neurological symptoms; less than 200 pg/mL is deficient
- Folate: If macrocytic anemia; deficiency less common with prenatal supplementation
- Iron studies (serum iron, TIBC, transferrin saturation): If ferritin equivocal or inflammation present
- Reticulocyte count: If recent hemorrhage to assess marrow response
If Suspecting Postpartum Psychosis or Atypical Presentation
First-Line Tests (Rule Out Organic Causes)
- All baseline tests above
- Comprehensive metabolic panel: Glucose, electrolytes, liver and kidney function
- Urine drug screen: Rule out substance-induced psychosis
- Urinalysis: Rule out urinary tract infection (can cause delirium)
Second-Line Tests (If Indicated)
- MRI brain: If focal neurological signs, seizures, or atypical presentation
- Lumbar puncture: If suspecting encephalitis or meningitis
- Autoimmune encephalitis panel: If psychosis unresponsive to treatment, movement disorder, seizures
- MR venography: If severe headache, seizures, or neurological signs (cerebral venous thrombosis)
- Ammonia, liver function: If suspecting hepatic encephalopathy
If Suspecting Sleep Disorder
Clinical Assessment First
- Sleep diary: 1-2 week record of sleep times, quality, awakenings
- STOP-BANG questionnaire: Screen for obstructive sleep apnea risk (Snoring, Tiredness, Observed apneas, Pressure/hypertension, BMI, Age, Neck circumference, Gender)
- Epworth Sleepiness Scale: Quantify daytime sleepiness
- Insomnia Severity Index: Quantify insomnia severity
Second-Line Tests
- Polysomnography (sleep study): If obstructive sleep apnea suspected (snoring, witnessed apneas, obesity, excessive daytime sleepiness)
- Home sleep apnea testing: Alternative to in-lab study for uncomplicated cases
- Actigraphy: Objective measure of sleep-wake patterns over 1-2 weeks; rarely needed
- Ferritin: If restless legs syndrome suspected; iron deficiency exacerbates RLS
If Suspecting Sheehan Syndrome (Postpartum Pituitary Necrosis)
When to Suspect Sheehan Syndrome
Consider in women with history of postpartum hemorrhage who present with:
- Failure to lactate (prolactin deficiency)
- Fatigue, weakness (cortisol deficiency)
- Cold intolerance, constipation (thyroid hormone deficiency)
- Amenorrhea (gonadotropin deficiency)
- Hypotension, hyponatremia
Investigations: Early morning cortisol, TSH, free T4, prolactin, LH, FSH, estradiol; MRI pituitary if clinical suspicion high
Investigation Summary by Clinical Scenario
| Clinical Scenario | Essential Investigations | Consider Adding |
|---|---|---|
| Routine postpartum mood screen positive | TSH, CBC, ferritin, EPDS/PHQ-9 | Vitamin D if risk factors |
| Moderate to severe depression | TSH, free T4, CBC, ferritin, BMP | Vitamin B12, folate if macrocytic; vitamin D |
| Anxiety-predominant presentation | TSH, CBC, GAD-7 | Consider ECG if palpitations prominent; caffeine assessment |
| Suspected postpartum psychosis | TSH, CBC, BMP, LFTs, urine drug screen, urinalysis | MRI brain, LP if atypical; autoimmune panel if treatment-resistant |
| History of postpartum hemorrhage | CBC, ferritin, reticulocyte count | Cortisol, pituitary hormones if symptoms suggest Sheehan syndrome |
| Suspected sleep apnea | STOP-BANG screening, TSH | Polysomnography or home sleep study if screening positive |
| Severe headache with mood changes | Neurological examination, blood pressure | MRI/MRV brain to rule out cerebral venous thrombosis |
Empiric Treatment Trials as Diagnostic Tools
Treatment Response Can Confirm Diagnosis
When the diagnosis is uncertain, response to empiric treatment can serve as a diagnostic tool:
- Iron supplementation trial: If ferritin low-normal (30-50 ng/mL) with fatigue — improvement in 4-6 weeks supports iron deficiency contribution
- Vitamin D supplementation: If deficient with fatigue and mood symptoms — improvement over 8-12 weeks supports vitamin D contribution
- Sleep hygiene and protected sleep trial: Arrange for partner or support person to provide nighttime infant care for 2-3 nights — if mood dramatically improves, sleep deprivation is major contributor
- SSRI trial: For moderate depression with negative medical workup — response by 4-6 weeks supports primary mood disorder
- CBT-I trial: For insomnia persisting beyond normal postpartum adjustment — response supports conditioned insomnia
When to Refer for Specialist Investigation or Care
| Situation | Referral | Urgency |
|---|---|---|
| Suicidal ideation with plan or intent | Psychiatry, emergency services | IMMEDIATE |
| Psychotic symptoms | Psychiatry, emergency services | IMMEDIATE |
| Suspected bipolar disorder | Psychiatry | URGENT (within days) |
| Treatment-resistant depression (failed 2 adequate trials) | Psychiatry, perinatal mental health specialist | URGENT |
| Complex thyroid disease | Endocrinology | Routine to urgent depending on severity |
| Suspected Sheehan syndrome | Endocrinology | URGENT |
| Suspected sleep apnea | Sleep medicine | Routine |
| Neurological symptoms, seizures, severe headache | Neurology, emergency services | IMMEDIATE to URGENT |
| Substance use disorder | Addiction medicine, counseling | URGENT |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for perinatal mood and sleep disturbances
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Suicidal ideation with plan or intent | EMERGENT | Do not leave patient alone; arrange immediate psychiatric evaluation; consider emergency department; ensure infant safety |
| Psychotic symptoms (delusions, hallucinations, disorganization) | EMERGENT | Immediate psychiatric hospitalization; separate mother and infant until safety assessed; postpartum psychosis is medical emergency |
| Thoughts of harming infant (command hallucinations or delusions) | EMERGENT | Immediate infant protection; psychiatric hospitalization; this is distinct from intrusive thoughts in OCD |
| Complete inability to sleep for 48+ hours with energy | EMERGENT | High risk for impending psychosis or mania; urgent psychiatric evaluation same day |
| Unable to care for self or infant (not eating, infant neglected) | URGENT | Arrange support for infant care; psychiatric evaluation within 24-48 hours; assess for severe depression or psychosis |
| Passive suicidal ideation (“wish I wasn’t here”) without plan | URGENT | Same-day or next-day mental health evaluation; safety planning; close follow-up; consider starting treatment |
| Severe depression with functional impairment | URGENT | Initiate treatment promptly; arrange mental health follow-up within 1-2 weeks; consider psychiatry referral |
| Moderate depression, EPDS 10-12, functional | ROUTINE | Discuss treatment options; arrange follow-up in 2-4 weeks; provide resources and support |
| Postpartum blues (days 2-14, improving) | ROUTINE | Reassurance and education; schedule follow-up at 2-week and 6-week visits to confirm resolution |
Safety Assessment Framework
For any patient with concerning symptoms, systematically assess:
- Suicidal ideation: Thoughts? Plan? Intent? Access to means? Prior attempts?
- Thoughts about infant: Intrusive thoughts (distressing, ego-dystonic) vs. psychotic (believes are true)?
- Ability to care for infant: Is infant safe? Fed? Clean? Attended to?
- Support system: Is there someone who can help? Can someone stay with her?
- Insight: Does she recognize she needs help? Will she accept help?
If ANY concern for immediate safety: Do not let patient leave alone. Arrange escort, emergency evaluation, or hospitalization as appropriate.
Step 2: Classify by Timing and Presentation
Days 1-14 Postpartum
If improving: Likely postpartum blues → reassurance, follow-up
If severe/worsening: Possible early depression or psychosis → close monitoring, consider early intervention
If psychotic features: Postpartum psychosis → EMERGENCY
Weeks 2-12 Postpartum
Peak risk period for postpartum depression and anxiety
Screen at all visits
Initiate treatment promptly if positive screen
Address sleep deprivation aggressively
Months 3-12 Postpartum
Depression can still develop or persist
Many women first present later in postpartum
Continue screening at all visits
Assess treatment response if on therapy
Step 3: Follow the Appropriate Pathway
Pathway A: Depression-Predominant Presentation
| Severity (EPDS/PHQ-9) | Clinical Features | Recommended Action |
|---|---|---|
| Mild (EPDS 10-12, PHQ-9 5-9) | Symptoms present but functioning; no suicidal ideation | Supportive counseling; sleep hygiene; consider psychotherapy (IPT, CBT); reassess in 2-4 weeks; medication if persists or worsens |
| Moderate (EPDS 13-17, PHQ-9 10-14) | Functional impairment; possible passive death wishes; difficulty caring for infant | Initiate treatment: psychotherapy AND/OR SSRI; close follow-up in 1-2 weeks; involve support system |
| Severe (EPDS ≥18, PHQ-9 15-19) | Significant impairment; may have suicidal ideation without plan | Start SSRI; consider psychiatry referral; weekly follow-up initially; safety planning; ensure infant care support |
| Very Severe (PHQ-9 ≥20, active suicidality) | Unable to function; suicidal ideation with plan; psychotic features | Urgent/emergent psychiatric evaluation; may require hospitalization; consider brexanolone if available; do not manage alone |
Pathway B: Anxiety-Predominant Presentation
| Type | Key Features | Recommended Action |
|---|---|---|
| Generalized anxiety | Excessive worry about infant, self, future; physical tension; difficulty relaxing | CBT first-line for mild-moderate; SSRI for moderate-severe; address sleep; avoid benzodiazepines long-term |
| Panic disorder | Recurrent panic attacks; fear of attacks; avoidance behaviors | SSRI first-line; CBT; short-term benzodiazepine for acute panic if not breastfeeding or with caution |
| Postpartum OCD | Intrusive thoughts (often about harming infant); compulsive checking; ego-dystonic | Reassure: these thoughts are common and do NOT mean she will act on them; SSRI (higher doses often needed); CBT with exposure response prevention |
| Postpartum PTSD | Following traumatic birth; flashbacks; nightmares; avoidance; hyperarousal | Trauma-focused therapy (CPT, EMDR, prolonged exposure); SSRI if comorbid depression; validate trauma experience |
Pathway C: Sleep-Predominant Presentation
| Scenario | Assessment | Management |
|---|---|---|
| Cannot sleep when infant sleeps (hyperarousal) | Screen for depression and anxiety — this is a red flag | Treat underlying mood disorder; if primary insomnia, CBT-I; short-term sedative-hypnotic may be considered |
| Sleep deprivation from infant care only | Confirm able to sleep when opportunity exists; no mood symptoms beyond fatigue | Sleep hygiene; partner/support involvement for nighttime feeds; “protected sleep” periods; will improve as infant matures |
| Cannot sleep + elevated energy (not tired) | Screen for mania/hypomania — this suggests bipolar | URGENT: Do NOT give antidepressant monotherapy; mood stabilizer needed; psychiatry referral |
| Snoring, witnessed apneas, daytime sleepiness | Screen for obstructive sleep apnea with STOP-BANG | Refer for sleep study; CPAP if confirmed; weight management; may significantly improve fatigue and mood |
Critical Decision Point: Screen for Bipolar Disorder BEFORE Starting Antidepressant
Ask every patient before initiating antidepressant treatment:
- “Have you ever had a period of feeling unusually high, energetic, or irritable — where you needed less sleep but still felt full of energy?”
- “Have you ever had a period where you felt like you could do anything, had racing thoughts, talked very fast, or did things that were out of character?”
- “Has anyone in your family been diagnosed with bipolar disorder?”
- “Have you ever been hospitalized for a psychiatric reason?”
If ANY positive responses: Do NOT start antidepressant monotherapy. Refer to psychiatry. Antidepressants can trigger mania or rapid cycling in bipolar disorder.
Step 4: Treatment Selection Guide
| Consideration | Preferred Approach | Notes |
|---|---|---|
| Mild symptoms, patient prefers non-medication | Psychotherapy (IPT or CBT), support groups, sleep hygiene, exercise | Reassess in 4-6 weeks; add medication if not improving |
| Moderate-severe symptoms or patient prefers medication | SSRI (sertraline or escitalopram preferred for breastfeeding) | Start low, titrate to therapeutic dose; response expected by 4-6 weeks |
| Previously responded to specific antidepressant | Restart the same medication | Prior response is best predictor of future response |
| Breastfeeding mother | Sertraline or paroxetine (lowest milk transfer); escitalopram acceptable | Benefits of breastfeeding and treated mother generally outweigh small medication exposure risks |
| Severe depression, rapid response needed | Consider brexanolone (if available) or SSRI + close monitoring | Brexanolone: IV infusion, 60-hour hospital stay, rapid response; limited availability |
| Bipolar history or suspected | Mood stabilizer (lamotrigine, lithium, or quetiapine); avoid antidepressant monotherapy | Requires psychiatry involvement; lithium requires monitoring; lamotrigine preferred for depression-predominant bipolar |
| Postpartum psychosis | Hospitalization + mood stabilizer + antipsychotic | Psychiatric emergency; usually managed by inpatient psychiatry; ECT highly effective if available |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient discloses suicidal thoughts | Stay calm; assess severity (thoughts vs. plan vs. intent); do not leave alone if high risk | Safety plan if low risk and able to contract for safety; emergency evaluation if high risk |
| Patient describes intrusive thoughts of harming infant | Differentiate OCD (ego-dystonic, distressing) from psychosis (ego-syntonic, may act) | If OCD: reassure, start SSRI, refer for CBT. If psychosis: emergency psychiatric evaluation |
| EPDS positive but patient denies symptoms | Explore gently; normalize; reframe questions; consider cultural factors | Repeat screening at next visit; provide resources; maintain supportive relationship |
| Patient refuses treatment | Explore barriers (stigma, concerns about medication, breastfeeding worries); provide education | Offer alternatives (therapy, support groups); ensure follow-up; document discussion |
| Partner/family concerned but patient minimizes | Interview patient privately; also gather collateral information with permission | Family observation is valuable; trust clinical judgment if discrepancy exists |
| No improvement after 4-6 weeks of SSRI | Confirm adherence; ensure adequate dose; reassess diagnosis | Increase dose if tolerated; if still no response, switch SSRI or add psychotherapy; consider psychiatry referral |
| Patient doing well, asks when to stop medication | Recommend continuing for at least 6-12 months after remission; longer if recurrent episodes | Taper slowly when ready (over months, not weeks); monitor for relapse; may need indefinite treatment |
| Pregnant patient on antidepressant asks if she should stop | Do NOT recommend abrupt discontinuation; weigh risks and benefits individually | Untreated depression has risks to pregnancy; most SSRIs acceptable; shared decision-making; may need dose adjustment in third trimester |
Troubleshooting: Refractory Mood or Sleep Symptoms
Ask These Questions When Treatment Is Not Working
- Is the diagnosis correct? Reconsider bipolar disorder, medical causes (thyroid), substance use, personality factors
- Is she taking the medication? Non-adherence is common; explore barriers (side effects, stigma, concerns)
- Is the dose adequate? Many patients are undertreated; ensure therapeutic dosing
- Has treatment duration been adequate? Full response may take 6-8 weeks; partial response may improve with more time
- Is sleep being addressed? Sleep deprivation perpetuates mood symptoms; ensure protected sleep time
- Are there ongoing stressors? Relationship problems, financial stress, lack of support undermine treatment
- Is there comorbidity? Anxiety, trauma, substance use may need specific treatment
- Is there unrecognized medical condition? Recheck thyroid, ferritin; consider other medical causes
Recommended Follow-up Schedule
| Situation | Follow-up Frequency | What to Assess |
|---|---|---|
| Postpartum blues, reassured | 2-week visit (can be telehealth); routine 6-week postpartum visit | Confirm symptoms resolved; re-screen; assess infant and maternal bonding |
| Newly started on medication | 1-2 weeks (phone/telehealth acceptable), then 4 weeks | Side effects; early response; suicidality (rare but possible emergence); adherence |
| Moderate-severe depression, starting treatment | Weekly for first 2-4 weeks, then every 2 weeks | Safety; symptom trajectory; medication tolerance; functioning |
| Stable on treatment, responding | Monthly initially, then every 2-3 months | Sustained remission; side effects; relapse signs; duration of treatment discussion |
| In remission, considering discontinuation | Monthly during and after taper | Relapse signs; slow taper; reinstate if symptoms return |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Critical Pitfalls to Avoid
Key Takeaways
- Perinatal mood disorders are common (affecting 15-20% of women), underdiagnosed, and highly treatable — screening should be universal at prenatal and postpartum visits.
- Postpartum blues (onset days 2-5, resolves by 2 weeks) is normal; postpartum depression (persistent beyond 2 weeks, with functional impairment) requires intervention.
- Postpartum psychosis is rare (1-2 per 1,000) but is a psychiatric emergency requiring immediate hospitalization — onset is usually within 2 weeks of delivery.
- The key sleep question is: “Can you sleep when the baby sleeps?” Inability to sleep despite opportunity is a red flag for pathology.
- Always screen for bipolar disorder before starting antidepressants — ask about prior elevated mood episodes and family history.
- Intrusive thoughts about infant harm are common in postpartum OCD (ego-dystonic, distressing); distinguish from psychotic beliefs (ego-syntonic, may act on).
- Check TSH, CBC, and ferritin in all patients with perinatal mood symptoms — thyroid dysfunction and iron deficiency are common and treatable mimics.
- SSRIs (especially sertraline) are first-line treatment and are generally compatible with breastfeeding; the risk of untreated maternal depression to infant development exceeds medication exposure risks.
- Sleep restoration is a primary treatment target — practical support for nighttime infant care, sleep hygiene, and treating insomnia directly improve mood outcomes.
- Suicide is a leading cause of maternal mortality — ask every patient directly about suicidal thoughts, and have a low threshold for urgent psychiatric referral.
Quick Reference Algorithm
Systematic Approach to Perinatal Mood and Sleep Disturbance:
- Screen systematically — Use EPDS or PHQ-9 at prenatal visits, 6-week postpartum, and any visit with concerns. Always review the self-harm question.
- Assess safety first — Ask directly about suicidal ideation, thoughts of harming infant, and ability to care for self and infant. Triage urgency accordingly.
- Determine timing and trajectory — Onset in days 1-14 and improving = likely blues. Onset later or persistent beyond 2 weeks = likely pathological. Acute onset with psychotic features = emergency.
- Screen for bipolar — Before any antidepressant, ask about prior manic symptoms and family history. If positive, refer to psychiatry.
- Order baseline investigations — TSH, CBC, ferritin for all patients to exclude medical mimics.
- Characterize presentation — Depression-predominant, anxiety-predominant, or sleep-predominant guides treatment selection.
- Initiate appropriate treatment — Mild: psychotherapy, support. Moderate-severe: SSRI +/- psychotherapy. Bipolar or psychosis: psychiatry involvement essential.
- Address sleep — Ensure practical support for protected sleep; treat insomnia if present.
- Engage support system — Involve partner and family in care plan.
- Follow up closely — Weekly initially for moderate-severe; ensure treatment response by 4-6 weeks; continue treatment for 6-12 months after remission.